The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma.

Huihsou FanWenqiang YanLingna LiJingyu XuJiahui LiuYan XuWeiwei SuiShuhui DengChenxing DuShuhua YiDehui ZouLugui QiuGang An

Published in: Hematology (Amsterdam, Netherlands) (2023)

We demonstrated that ISS/RISS re-staging showed superior prognostic utility over ISS/RISS staging in predicting PPS. Patients with deteriorated stage migration or maintained advanced stage at progression may need more individualized treatment.

Keyphrases

multiple myeloma
lymph node
pet ct